Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Ricerca Biosciences, a preclinical contract research organization (CRO) that provides services to the biopharmaceutical industry, have entered into an agreement with Fulcrum Pharma and Aptiv Solutions to create a streamlined and efficient process to advance a candidate from development to clinical evaluation.
Subscribe to our email newsletter
Aptiv Solutions provides drug development consulting and regulatory services essential to progress a development program from research to product approval.
Ricerca CEO Ian Lennox said the Fulcrum Pharma collaboration is an attractive and exciting proposition for Ricerca and their clients.
"Fulcrum Pharma brings deep experience in IND authorship and regulatory approval, which fits well with Ricerca’s preclinical services in discovery pharmacology, chemical development and drug safety assessment," Lennox said.